Expression of FoxM1 and the EMT-associated Protein E-cadherin in Gastric Cancer and Its Clinical Significance

Overview

Journal Oncol Lett

Specialty Oncology

Date 2016 Oct 5

PMID 27698811

Citations 15

Authors

Jing Zhang

Xiao-Yu Chen

Ke-Jian Huang

Wei-Dong Wu

Tao Jiang

Jun Cao

Li-Sheng Zhou

Zheng-Jun Qiu

Chen Huang

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to investigate the expression of forkhead box M1 (FoxM1) and E-cadherin in tissues of gastric cancer in order to reveal any correlation between FoxM1, E-cadherin and clinicopathological parameters. The association between FoxM1 and E-cadherin in the development and progression of gastric cancer was also investigated. The expression of FoxM1 and E-cadherin in gastric cancer and adjacent normal tissue on tissue microarray was detected using immunohistochemistry. The clinicopathological significance of FoxM1 and E-cadherin in gastric cancer was explored, and the association between FoxM1 and E-cadherin was further examined using statistical techniques. In gastric cancer tissues, the expression of FoxM1 and E-cadherin was strongly positive, but it was weak in normal gastric mucosa. Overexpression of FoxM1 was evident in gastric cancer, and was associated with poor tumor differentiation (P<0.05), advanced tumor state (P<0.05) and lymph node (or distant) metastasis (P<0.05), whereas E-cadherin had the opposite effects. Furthermore, the correlation between FoxM1 and E-cadherin expression in gastric cancer tissue was negative. In conclusion, the high FoxM1 expression and low E-cadherin expression in gastric cancer tissue suggests that these proteins play a critical role in the development and progression of gastric cancer.

Citing Articles

Laminarin Attenuates ROS-Mediated Cell Migration and Invasiveness through Mitochondrial Dysfunction in Pancreatic Cancer Cells.

Lee W, Song G, Bae H Antioxidants (Basel). 2022; 11(9).

PMID: 36139787 PMC: 9495390. DOI: 10.3390/antiox11091714.

A narrative review of research progress on FoxM1 in breast cancer carcinogenesis and therapeutics.

Zhang Y, Ma Y, Zeng Y, Liu Y, He E, Liu Y Ann Transl Med. 2022; 9(22):1704.

PMID: 34988213 PMC: 8667115. DOI: 10.21037/atm-21-5271.

Downregulation of lncRNA inhibits proliferation and migration of mesothelioma cells by targeting .

Fujii Y, Amatya V, Kushitani K, Suzuki R, Kai Y, Kambara T Oncol Rep. 2021; 47(2).

PMID: 34859258 PMC: 8674703. DOI: 10.3892/or.2021.8238.

Epithelial expression of epithelia-cadherin in different grades of oral squamous cell carcinoma.

Kar D, Banerjee S J Oral Maxillofac Pathol. 2021; 25(2):253-257.

PMID: 34703118 PMC: 8491325. DOI: 10.4103/0973-029X.325123.

Circular PVT1 regulates cell proliferation and invasion via miR-149-5p/FOXM1 axis in ovarian cancer.

Li M, Chi C, Zhou L, Chen Y, Tang X J Cancer. 2021; 12(2):611-621.

PMID: 33391456 PMC: 7738991. DOI: 10.7150/jca.52234.

References

Yatsuya H, Toyoshima H, Mizoue T, Kondo T, Tamakoshi K, Hori Y . Family history and the risk of stomach cancer death in Japan: differences by age and gender. Int J Cancer. 2002; 97(5):688-94. DOI: 10.1002/ijc.10101. View

Kong F, Zhu Y, Yuan H, Wang J, Zhao M, Gong X . FOXM1 regulated by ERK pathway mediates TGF-β1-induced EMT in NSCLC. Oncol Res. 2015; 22(1):29-37. PMC: 7592790. DOI: 10.3727/096504014X14078436004987. View

Halasi M, Gartel A . Targeting FOXM1 in cancer. Biochem Pharmacol. 2012; 85(5):644-652. DOI: 10.1016/j.bcp.2012.10.013. View

Tang W, Zhu Y, Gao J, Fu J, Liu C, Liu Y . MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4. Br J Cancer. 2013; 110(2):450-8. PMC: 3899762. DOI: 10.1038/bjc.2013.724. View

Wang Y, Yao B, Wang Y, Zhang M, Fu S, Gao H . Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer. Int J Mol Med. 2014; 33(6):1514-22. DOI: 10.3892/ijmm.2014.1707. View

Huang C, Qiu Z, Wang L, Peng Z, Jia Z, Logsdon C . A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis. Cancer Res. 2011; 72(3):655-65. PMC: 3271134. DOI: 10.1158/0008-5472.CAN-11-3102. View

Nagini S . Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol. 2012; 4(7):156-69. PMC: 3406280. DOI: 10.4251/wjgo.v4.i7.156. View

Li X, Tang D, Yao Y, Qi W, Liang J . Clinical significance and positive correlation of FoxM1 and Her-2 expression in gastric cancer. Clin Exp Med. 2013; 14(4):447-55. DOI: 10.1007/s10238-013-0261-6. View

Chu X, Zhu Z, Chen L, Wang J, Su Q, Yang J . FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer. Acta Histochem. 2012; 114(8):755-62. DOI: 10.1016/j.acthis.2012.01.002. View

10.

Li Q, Zhang N, Jia Z, Le X, Dai B, Wei D . Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res. 2009; 69(8):3501-9. PMC: 4087044. DOI: 10.1158/0008-5472.CAN-08-3045. View

11.

Huang C, du J, Xie K . FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis. Biochim Biophys Acta. 2014; 1845(2):104-16. PMC: 3995850. DOI: 10.1016/j.bbcan.2014.01.002. View

12.

Meng F, Wei J, Qu K, Wang Z, Wu Q, Tai M . FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. World J Gastroenterol. 2015; 21(1):196-213. PMC: 4284335. DOI: 10.3748/wjg.v21.i1.196. View

13.

Koo C, Muir K, Lam E . FOXM1: From cancer initiation to progression and treatment. Biochim Biophys Acta. 2011; 1819(1):28-37. DOI: 10.1016/j.bbagrm.2011.09.004. View

14.

Wei P, Zhang N, Wang Y, Li D, Wang L, Sun X . FOXM1 promotes lung adenocarcinoma invasion and metastasis by upregulating SNAIL. Int J Biol Sci. 2015; 11(2):186-98. PMC: 4279094. DOI: 10.7150/ijbs.10634. View

15.

Yang C, Chen H, Tan G, Gao W, Cheng L, Jiang X . FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer. Cancer Lett. 2013; 340(1):104-12. DOI: 10.1016/j.canlet.2013.07.004. View

16.

van Roy F . Beyond E-cadherin: roles of other cadherin superfamily members in cancer. Nat Rev Cancer. 2014; 14(2):121-34. DOI: 10.1038/nrc3647. View

17.

Zhou Y, Ming J, Xu Y, Zhang Y, Jiang J . ERβ1 inhibits the migration and invasion of breast cancer cells through upregulation of E-cadherin in a Id1-dependent manner. Biochem Biophys Res Commun. 2014; 457(2):141-7. DOI: 10.1016/j.bbrc.2014.12.038. View

18.

Cho J . Molecular diagnosis for personalized target therapy in gastric cancer. J Gastric Cancer. 2013; 13(3):129-35. PMC: 3804671. DOI: 10.5230/jgc.2013.13.3.129. View

19.

Bella L, Zona S, Nestal de Moraes G, Lam E . FOXM1: A key oncofoetal transcription factor in health and disease. Semin Cancer Biol. 2014; 29:32-9. DOI: 10.1016/j.semcancer.2014.07.008. View

20.

Li D, Wei P, Peng Z, Huang C, Tang H, Jia Z . The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis. Clin Cancer Res. 2012; 19(1):62-72. PMC: 3537853. DOI: 10.1158/1078-0432.CCR-12-1588. View